Unilateral radiation nephropathy--the long-term significance

Area of Science:

• Oncology
• Nephrology
• Radiology

Background:

• Gastrointestinal and retroperitoneal non-Hodgkin's lymphoma are treated with abdominal radiotherapy.
• Radiotherapy can affect kidney function, leading to radiation nephropathy.

Purpose of the Study:

• To evaluate the incidence and long-term effects of unilateral radiation nephropathy in patients treated with abdominal radiotherapy for non-Hodgkin's lymphoma.
• To identify risk factors and clinical outcomes associated with radiation-induced kidney damage.

Main Methods:

• Eighteen patients received abdominal radiotherapy (2200-4500 cGy).
• Renal function was assessed using 99m Tc glucoheptonate and I-131 radio-hippurate studies.
• Patients were followed for 5-8 years, monitoring creatinine clearance, beta-2 microglobulin, and blood pressure.

Main Results:

• Nine patients developed unilateral radiation nephropathy.
• The minimum nephro-pathogenic dose was 2200 cGy in 59 days; higher doses increased incidence.
• Renal function recovery was observed in some patients, but atrophic changes were irreversible in others.
• Abnormal creatinine clearance and beta-2 microglobulin indicated vascular damage; elevated blood pressure was managed medically.

Conclusions:

• Unilateral radiation nephropathy is a risk following abdominal radiotherapy for lymphoma.
• Kidney damage is dose-dependent, with potential for both recovery and irreversible changes.
• Medical management of complications like hypertension is effective, avoiding nephrectomy in most cases.